Correction to Story on Johnson & Johnson's Schizophrenia Drug
May 19 2015 - 11:06AM
Dow Jones News
The story on Johnson & Johnson's schizophrenia drug at 9:13
a.m. ET misstated the news. The U.S. Food and Drug Administration
approved the drug for sale; the earlier story incorrectly said the
drug was approved for priority review.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2024 to Oct 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Oct 2023 to Oct 2024